Innova Captab Limited
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.
What Innova files
- Others41
- Investor Meet38
- Important17
- Board Meeting14
- Updates11
- PPTs6
Innova Captab will expand its Baddi facility with two new Oral Solid Dosage production lines for 45 Cr. This brownfield expansion, funded by bank credit and internal accruals, is expected to complete in 18-22 months, boosting capacity, efficiency, and supporting long-term growth.
Innova Captab has announced a board meeting on Tuesday, 11th August, 2026, to consider Q1 standalone and consolidated financial results. They will also approve revised audited financial results for the previous quarter and full year due to an immaterial error.
Innova Captab's proposed GST demand of ₹15.81 Cr and penal proceedings were dropped by tax authorities. This concludes the matter with no financial liability for the company.
Innova Captab announced an interim dividend of ₹2 per share (20% of face value) for FY25-26. Dividend income is taxable, so TDS applies. Shareholders need to submit documents for accurate TDS rates and update bank details for electronic payments.
Innova Captab has announced a board meeting on Friday, 23rd January, 2026, to consider financial results for the quarter and nine months ended 31st December, 2025. The board will also discuss a potential interim dividend for FY25-26, with the record date set for Friday, 30th January, 2026, if declared.